ASH 2025 Highlights:

MajesTEC-3: Teclistamab + Daratumumab in relapse refractory Multiple Myeloma

Paradigm: HMA + Ven vs. 7+3 or CPX-351

Denosumab safety & dosing in Multiply Myeloma and renal dysfunction

Trilaciclib and CDK 4/6 inhibition as protection against TP53-mutated clonal hematopoiesis?

ASH 2025 Highlights: MajesTEC-3: Teclistamab + Daratumumab in relapse refractory Multiple Myeloma Paradigm: HMA + Ven vs. 7+3 or CPX-351 Denosumab safety & dosing in Multiply Myeloma and renal dysfunction Trilaciclib and CDK 4/6 inhibition as protection against TP53-mutated clonal hematopoiesis?

ASH 2025 Highlights:

MajesTEC-3: Teclistamab + Daratumumab in relapse refractory Multiple Myeloma

Paradigm: HMA + Ven vs. 7+3 or CPX-351

Denosumab safety &amp; dosing in Multiply Myeloma and renal dysfunction

Trilaciclib and CDK 4/6 inhibition as protection against TP53-mutated clonal hematopoiesis?

ASH 2025

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Science

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

Share ASH 2025

Sign up to save your podcasts

ASH 2025

ASH 2025

More shows like OncoPharm

JAMA Clinical Reviews

The Daily

Up First from NPR

Armchair Expert with Dax Shepard

ASCO Guidelines

The Peter Attia Drive

OncLive® On Air

Raising Good Humans

Oncology Today with Dr Neil Love

Huberman Lab

The Money with Katie Show

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

WolverHeme Happy Hour

Good Hang with Amy Poehler